102 related articles for article (PubMed ID: 26445605)
1. Reappraisal of the role of postoperative radiation therapy in patients with pIIIa-N2 non-small cell lung cancer: A propensity score matching analysis.
Cao Q; Zhang B; Zhao L; Wang C; Gong L; Wang J; Pang Q; Li K; Liu W; Li X; Wang P; Wang P
Thorac Cancer; 2015 Sep; 6(5):570-8. PubMed ID: 26445605
[TBL] [Abstract][Full Text] [Related]
2. The impact of positive nodal chain ratio on individualized multimodality therapy in non-small-cell lung cancer.
Cao Q; Zhang B; Zhao L; Wang C; Gong L; Wang J; Pang Q; Li K; Liu W; Li X; Wang P; Wang P
Tumour Biol; 2015 Jun; 36(6):4617-25. PubMed ID: 25623115
[TBL] [Abstract][Full Text] [Related]
3. Role of postoperative radiotherapy after curative resection and adjuvant chemotherapy for patients with pathological stage N2 non-small-cell lung cancer: a propensity score matching analysis.
Kim BH; Kim HJ; Wu HG; Kang CH; Kim YT; Lee SH; Kim DW
Clin Lung Cancer; 2014 Sep; 15(5):356-64. PubMed ID: 24996882
[TBL] [Abstract][Full Text] [Related]
4. The addition of radiotherapy to adjuvant chemotherapy has a combinatorial effect in pN2 non-small cell lung cancer only with extranodal invasion or multiple N2 metastasis.
Yun JK; Lee GD; Choi S; Kim HR; Kim YH; Park SI; Kim DK
Lung Cancer; 2021 May; 155():94-102. PubMed ID: 33765654
[TBL] [Abstract][Full Text] [Related]
5. Prognostic Significance of the Number of Metastatic pN2 Lymph Nodes in Stage IIIA-N2 Non-Small-Cell Lung Cancer After Curative Resection.
Yoo C; Yoon S; Lee DH; Park SI; Kim DK; Kim YH; Kim HR; Choi SH; Kim WS; Choi CM; Jang SJ; Song SY; Kim SS; Choi EK; Lee JC; Suh C; Lee JS; Kim SW
Clin Lung Cancer; 2015 Nov; 16(6):e203-12. PubMed ID: 25997733
[TBL] [Abstract][Full Text] [Related]
6. Skip mediastinal lymph node metastasis and lung cancer: a particular N2 subgroup with a better prognosis.
Riquet M; Assouad J; Bagan P; Foucault C; Le Pimpec Barthes F; Dujon A; Danel C
Ann Thorac Surg; 2005 Jan; 79(1):225-33. PubMed ID: 15620948
[TBL] [Abstract][Full Text] [Related]
7. [Value of metastatic lymph node ratio in predicting the prognosis of non-small cell lung cancer patients].
Li Y; Sun BS; Zhang ZF; Zhang LM; Wang CL
Zhonghua Yi Xue Za Zhi; 2011 Jun; 91(24):1682-6. PubMed ID: 21914316
[TBL] [Abstract][Full Text] [Related]
8. Prognostic factors after complete resection of pN2 non-small cell lung cancer.
Sonobe M; Date H; Wada H; Okubo K; Hamakawa H; Teramukai S; Matsumura A; Nakagawa T; Sumitomo S; Miyamoto Y; Okumura N; Takeo S; Kawakami K; Aoki M; Kosaka S;
J Thorac Cardiovasc Surg; 2013 Oct; 146(4):788-95. PubMed ID: 23810113
[TBL] [Abstract][Full Text] [Related]
9. Metastatic lymph node size and colorectal cancer prognosis.
Dhar DK; Yoshimura H; Kinukawa N; Maruyama R; Tachibana M; Kohno H; Kubota H; Nagasue N
J Am Coll Surg; 2005 Jan; 200(1):20-8. PubMed ID: 15631916
[TBL] [Abstract][Full Text] [Related]
10. The prognostic impact of main bronchial lymph node involvement in non-small cell lung carcinoma: suggestions for a modification of the staging system.
Shimada Y; Tsuboi M; Saji H; Miyajima K; Usuda J; Uchida O; Kajiwara N; Ohira T; Hirano T; Kato H; Ikeda N
Ann Thorac Surg; 2009 Nov; 88(5):1583-8. PubMed ID: 19853116
[TBL] [Abstract][Full Text] [Related]
11. Proposed Modification of the pN2 Classification of the 8th Edition AJCC Staging System for Esophageal Squamous Cell Carcinoma: A Preliminary Study Based on the Chinese Population.
Xi K; Yu H
J Oncol; 2021; 2021():8871884. PubMed ID: 33777143
[TBL] [Abstract][Full Text] [Related]
12. Volume-Based Assessment With 18F-FDG PET/CT Improves Outcome Prediction for Patients With Stage IIIA-N2 Non-Small Cell Lung Cancer.
Hyun SH; Ahn HK; Ahn MJ; Ahn YC; Kim J; Shim YM; Choi JY
AJR Am J Roentgenol; 2015 Sep; 205(3):623-8. PubMed ID: 26295651
[TBL] [Abstract][Full Text] [Related]
13. Prognostic significance of surgical-pathologic multiple-station N1 disease in non-small cell carcinoma of the lung.
Sayar A; Turna A; Kiliçgün A; Solak O; Urer N; Gürses A
Eur J Cardiothorac Surg; 2004 Mar; 25(3):434-8. PubMed ID: 15019674
[TBL] [Abstract][Full Text] [Related]
14. Long-term survival of patients with pN2 lung cancer according to the pattern of lymphatic spread.
Legras A; Mordant P; Arame A; Foucault C; Dujon A; Le Pimpec Barthes F; Riquet M
Ann Thorac Surg; 2014 Apr; 97(4):1156-62. PubMed ID: 24582052
[TBL] [Abstract][Full Text] [Related]
15. The impact of multiple metastatic nodal stations on survival in patients with resectable N1 and N2 nonsmall-cell lung cancer.
Kang CH; Ra YJ; Kim YT; Jheon SH; Sung SW; Kim JH
Ann Thorac Surg; 2008 Oct; 86(4):1092-7. PubMed ID: 18805138
[TBL] [Abstract][Full Text] [Related]
16. [Impact of TNM staging and treatment mode on the prognosis of non-small cell lung cancer].
Yu DP; Bai LQ; Xu SF; Han M; Wang ZT
Zhonghua Zhong Liu Za Zhi; 2009 Jun; 31(6):465-8. PubMed ID: 19950561
[TBL] [Abstract][Full Text] [Related]
17. Adjuvant radiotherapy and lymph node dissection in pancreatic cancer treated with surgery and chemotherapy.
Mellon EA; Springett GM; Hoffe SE; Hodul P; Malafa MP; Meredith KL; Fulp WJ; Zhao X; Shridhar R
Cancer; 2014 Apr; 120(8):1171-7. PubMed ID: 24390779
[TBL] [Abstract][Full Text] [Related]
18. Role of skip metastasis to mediastinal lymph nodes in non-small cell lung cancer.
Prenzel KL; Mönig SP; Sinning JM; Baldus SE; Gutschow CA; Grass G; Schneider PM; Hölscher AH
J Surg Oncol; 2003 Apr; 82(4):256-60. PubMed ID: 12672010
[TBL] [Abstract][Full Text] [Related]
19. The impact of an N1 lymph node examination in patients with early-stage non-small cell lung cancer: a retrospective cohort study.
Zhai W; Zheng Y; Rong Y; Li X; Yan Q; Duan F; Zhao Z; Chen J; Dai S; Wang J
J Thorac Dis; 2021 Apr; 13(4):2184-2193. PubMed ID: 34012569
[TBL] [Abstract][Full Text] [Related]
20. Prognostic significance of surgical-pathologic N1 lymph node involvement in non-small cell lung cancer.
Demir A; Turna A; Kocaturk C; Gunluoglu MZ; Aydogmus U; Urer N; Bedirhan MA; Gurses A; Dincer SI
Ann Thorac Surg; 2009 Apr; 87(4):1014-22. PubMed ID: 19324121
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
